Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, and pharmacokinetics of EVP-6124 (encenicline) in schizophrenia and schizoaffective disorder, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• EVP-6124

Snippet

Sponsor: FORUM Pharmaceuticals Inc | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED | Results posted: 2012-06-21